Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 693-697, June 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okamura, N.
Right arrow Articles by Busch, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okamura, N.
Right arrow Articles by Busch, H.

Base Composition of High Molecular Weight Nuclear RNA of Walker Tumor and Liver of the Rat1

Nobuko Okamura2 and Harris Busch

( Department of Pharmacology, Baylor University College of Medicine, Houston, Texas)

The high molecular weight nuclear RNA3 of the Walker 256 carcinosarcoma and normal rat liver was fractionated into 45 S and 55 S components by means of repeated sucrose density gradient centrifugations. The RNA was characterized by base composition determined by ultraviolet analysis and by distribution of 32P-orthophosphate after pulse-labeling in vivo. In both the tumor and normal liver, the 45 S RNA had a relatively higher content of guanylic and cytidylic acid than the 55 S fraction. Ultraviolet absorption analysis showed that both the 45 S and the 55 S RNA of the Walker tumor had a significantly lower content of adenylic and uridylic acids than the corresponding fractions from the normal liver. Studies with 32P-orthophosphate revealed that the rapidly-labeled high molecular weight RNA of the Walker tumor had a markedly lower content of adenylic acid than the rapidly-labeled RNA of the liver. These data are supportive of the concept that there are significant differences in the RNA produced by the Walker tumor and the liver.

1 These studies were supported in part by grants from the National Science Foundation, the USPHS (CA-05421, CA-07201), the Jane Coffin Childs Fund, and the American Cancer Society.

3 The following abbreviations are used: A, adenine or adenylic acid; A+U/G+C, ratio of the sum of the percentages of bases in adenylic and uridylic acids to the sum of the bases in guanylic and cytidylic acids, or the ratio of the sum of the percentages of the total 32P in adenylic and uridylic acids to the sum of the percentages of the total 32P in guanylic and cytidylic acids; C, cytosine or cytidylic acid; DNA, deoxyribonucleic acid; EDTA, disodium ethylenediamine tetraacetate; G, guanine or guanylic acid; PCA, perchloric acid; RNA, ribonucleic acid; S, sedimentation coefficient; SDS, sodium dodecylsulfate; U, uracil or uridylic acid.

2 On leave from the Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University, Sendai, Japan.

Received 12/11/64.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.